Literature DB >> 6114688

Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride.

B R Newman, L K Schultz.   

Abstract

A patient taking propranolol hydrochloride, 40 mg twice daily, had a constitutional reaction several minutes after receiving a maintenance allergy injection. When the reaction proved resistant to treatment with aqueous adrenalin, intubation with 100% oxygen ventilation and the intravenous administration of sodium bicarbonate with pancuronium bromide, diphenhydramine hydrochloride and dexamethasone was required for the patient's recovery. Physicians should be aware that, in allergy patients, low doses of propranolol hydrochloride can result in acute pulmonary failure.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6114688

Source DB:  PubMed          Journal:  Ann Allergy        ISSN： 0003-4738


  9 in total

1.  Anaphylaxis--everyone's problem.

Authors:  G N Beall; R Casaburi; A Singer
Journal:  West J Med       Date:  1986-03

Review 2.  Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?

Authors:  David M Lang
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

Review 3.  The risk and management of anaphylaxis in the setting of immunotherapy.

Authors:  Phil Lieberman
Journal:  Am J Rhinol Allergy       Date:  2012 Nov-Dec       Impact factor: 2.467

4.  Skin prick testing in patients using beta-blockers: a retrospective analysis.

Authors:  Irene N Fung; Harold L Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2010-01-20       Impact factor: 3.406

Review 5.  Beta-blocker therapy and the risk of anaphylaxis.

Authors:  J H Toogood
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

Review 6.  Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.

Authors:  C Steinberg; D A Notterman
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

Review 7.  Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers.

Authors:  D M Lang
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

8.  Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Matthias Fischer; Thomas Fuchs; Axel Heller; Florian Hoffmann; Isidor Huttegger; Thilo Jakob; Ludger Klimek; Matthias V Kopp; Claudia Kugler; Lars Lange; Oliver Pfaar; Ernst Rietschel; Franziska Rueff; Sabine Schnadt; Roland Seifert; Britta Stöcker; Regina Treudler; Christian Vogelberg; Thomas Werfel; Margitta Worm; Helmut Sitter; Knut Brockow
Journal:  Allergo J Int       Date:  2021-01-28

Review 9. 

Authors:  Johannes Ring; Kirsten Beyer; Tilo Biedermann; Andreas Bircher; Matthias Fischer; Axel Heller; Isidor Huttegger; Thilo Jakob; Ludger Klimek; Matthias V Kopp; Claudia Kugler; Lars Lange; Oliver Pfaar; Ernst Rietschel; Franziska Rueff; Sabine Schnadt; Roland Seifert; Britta Stöcker; Regina Treudler; Christian Vogelberg; Thomas Werfel; Margitta Worm; Helmut Sitter; Knut Brockow
Journal:  Allergo J       Date:  2021-02-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.